By DAVID INTROCASO In late July the UN International Court of Justice (ICJ) announced its long-awaited and highly-anticipated climate advisory opinion. The ICJ ruling represents an historic moment in climate accountability. “Obligations of States in Respect of Climate Change” In a rare unanimous decision, the ICJ opinion concluded “a clean, healthy and sustainable environment” is in…
Bristol Myers Squibb’s Cobenfy treats schizophrenia by going after a different target than currently available antipsychotic drugs, which is intended to offer better efficacy and safety. The drug came from the pharma giant’s $14 billion acquisition of Karuna Therapeutics. The post FDA Approval of Bristol Myers Drug Makes It the First Novel Schizophrenia Med in…
The Host Julie Rovner KFF Health News @jrovner Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A to…
Those who act first will lower cost to serve, boost rep productivity and deliver customer experiences that feel personal, not programmatic. Those who wait risk falling behind as competitors turn engagement into a true differentiator. The post Pharma’s Make-or-Break Moment: How AI Is Rewriting the Rules of Customer Engagement appeared first on MedCity News.
Brepocitinib is on track for pivotal testing after meeting the goals of a proof-of-concept study in cutaneous sarcoidosis, a rare inflammatory skin disorder with no FDA-approved therapies. Roivant Sciences subsidiary Priovant Therapeutics licensed the dual JAK1 and TYK2 inhibitor from Pfizer. The post Clinical Trial Win Bolsters Blockbuster Prospects for Roivant Rare Disease Drug Licensed…
On Monday, April 7, Judge Matthew Kacsmaryk in the US District Court for Northern Texas ruled to overturn key elements of a Biden administration rule that established the first-ever minimum staffing ratios for nursing facilities.
By MATT McCORD Using opioids to treat acute pain is a lot like burning coal to power our homes. Both are legacy solutions from an earlier era. Both were once celebrated as breakthroughs. And both have since proven to be dirty, dangerous, and incredibly costly to clean up. Despite this, we continue to rely on…
Major federal changes to Medicaid and other health-related policies could impact children’s health in the coming years. This issue brief explores the latest data on Medicaid and children’s health and highlights five key issues to watch as those federal changes are implemented.
Lavonia Thomas, nursing informatics officer at MD Anderson Cancer Center, hopes that nurses will gain more access to ambient listening tools that listen in on patient conversations and then generate summaries for documentation purposes. These AI tools have become popular among physicians in the past couple years. The post This Hospital Exec Wants Nurses Should…
Judging by more than 16,400 comments recently posted on a federal government website, you’d think there was a groundswell of older Americans demanding that federal officials hike payments to their Medicare Advantage health insurance plans. Yet about 82% of the comments are identical to a letter that appeared on the website of a secretive advocacy…